This is an original U.S. patent application.
The invention relates to nasal dilators. More specifically, the invention relates to nasal-dilator configurations that provide improved wearing comfort.
Dilators to improve breathing by expanding a person's nasal passages have been investigated and developed for many decades. One of the earliest external nasal dilator devices is described in U.S. Pat. No. 1,292,083 to Sawyer, and a simple forerunner of contemporary external nasal dilators was described in Spanish utility model ES_289-561 in 1985.
With the development of modern materials (including nonwoven fabrics, breathable films, and sturdy, lightweight resilient plastic sheet materials), most recent dilators have adopted one of three basic forms, shown in
Note that some prior-art dilators blur the boundaries between “hot dog,” “dog bone” and “butterfly.” For example, U.S. Pat. No. 5,533,499 to Johnson discloses a dilator whose overall shape is that of a dog bone, but whose resilient members terminate short of the dilator ends, so they are island-placed.
All contemporary dilators must address several common challenges: first, they must adhere securely enough to avoid peeling off inadvertently, yet not adhere so aggressively that the user's skin is damaged when they are removed intentionally. Second, they must be comfortable for long-term (often overnight) wear. And finally, they must provide a consistent, reliable spring force to stabilize the skin and tissue over the user's nasal valve, and thereby to help open the user's nasal passages for improved respiration.
One occurrence that adversely impacts user comfort is the accumulation of moisture under the dilator—the skin to which the dilator is adhered may transpire or sweat, and the combination of perspiration and adhesive may cause itching. In some embodiments, adhesive-free areas or even absorbent pads are used to reduce the area where itching may occur. Other designs use special materials with higher moisture vapor transmission rates (MVTR). However, these materials are often more expensive than traditional materials, or are harder to work with.
Alternative approaches to reducing moisture-trapping surface area in a nasal dilator may be of substantial value in this area of technology.
Embodiments of the invention are dog-bone style nasal dilators whose resilient members are positioned differently from the prior art, so that the breathable surface area of the dilator within the resilient structure's boundaries is substantially increased.
An embodiment of the invention is a dog-bone style nasal dilator, generally similar to the device 100 depicted in
Dilator 100 is an oblong structure which may be divided into three regions along its length: lateral end regions 132, 134 are interconnected by a narrower “waist” region 136. Similarly, across its width, the dilator may be divided into two outer portions 135 flanking a central band 137. The central band 137 includes two resilient members 122a, 122b, which extend fully from end to end of the dilator. (End-to-end resilient members allow the dilator to be manufactured more accurately and efficiently, compared to island-placed resilient members.) In use, the narrow waist region 136 is placed across the bridge of the nose, and the lateral end regions 132, 134 are pressed down and adhered against the sides of the nose and the cheeks. The resilient members are thus flexed over the bridge of the nose, and in attempting to spring back to their unflexed configuration, they lift and stabilize the skin to which they are adhered, thus opening and dilating the user's nasal passages. The outer portions 135 include corner tabs (sometimes called “tab extensions” or “wings”) that aid in maintaining the lateral end regions 132 and 134 secured to the skin of the nose. The distinguishing characteristics of an embodiment lie mostly within the central band 137, which may be viewed as a “resilient structure bounding box” 199, outlined in heavy dashed lines.
The difference in surface area coverage is important because the material used for all nasal dilator resilient members is typically a nonpermeable or low-permeability plastic such as polyethyl tetraphthalate (“PET” or biaxially-oriented polyethyl tetraphthalate, “boPET”). The other portions of the resilient member bounding box may be covered by a permeable material such as a woven or nonwoven fabric or a breathable plastic film (or, in some embodiments described below, by nothing at all—i.e., by an opening that exposes the skin directly to the atmosphere). By reducing the amount of skin covered by the resilient-member material, an embodiment improves skin breathability and reduces moisture vapor accumulation, and thus improves device comfort.
The principal distinguishing characteristic of an embodiment is the proportion of the resilient-member surface area that is covered by low-permeability or impermeable resilient members, compared to the total surface area of bounding box 199/central band 137. An embodiment reduces that proportion (with a corresponding increase in the higher-permeability area of non-resilient-member engagement layer surface area), by making the resilient members slightly narrower, and by separating the resilient members by a greater distance, while maintaining substantially the same central band width and spring force resiliency as the prior art. Some embodiments increase the effective MVTR of the bounding box area by piercing or removing some of the engagement layer within that area.
Note that the nasal dilator embodiments depicted in the foregoing figures are proportioned substantially accurately, although some material thicknesses are slightly exaggerated in some views for clarity. In particular, plan-view widths, lengths, and therefore surface areas, are proportioned so that they can be directly compared by visual inspection. Numerically, an embodiment is distinguished by a resilient structure bounding box where no more than 57.5% of the total area is occupied by low-permeability or impermeable resilient members. In other words, considering the length and width of the resilient members and the gap(s) separating them, the area covered by the resilient members is 57.5% or less. The thickness of the resilient members can be adjusted to increase resiliency as necessary to attain the target resilient or spring force, measured as detailed below, of between about 15 grams and about 45 grams.
In a preferred embodiment, the area of the resilient structure bounding box covered by low-permeability or impermeable resilient members is about 47%—less than half. An embodiment may comprise even narrower (though thicker) resilient members. The practical lower limit is about 40-43%—beyond that limit, the resilient members become unreasonably thick, complicating manufacturing procedures.
The applications of the present invention have been described largely by reference to specific examples. Variations from the specific examples are understood to be captured according to the following claims.
Number | Name | Date | Kind |
---|---|---|---|
5476091 | Johnson | Dec 1995 | A |
5479944 | Petruson | Jan 1996 | A |
5533499 | Johnson | Jul 1996 | A |
5533503 | Doubek et al. | Jul 1996 | A |
5546929 | Muchin | Aug 1996 | A |
5549103 | Johnson | Aug 1996 | A |
RE35408 | Petruson | Dec 1996 | E |
5611333 | Johnson | Mar 1997 | A |
5653224 | Johnson | Aug 1997 | A |
5706800 | Cronk et al. | Jan 1998 | A |
5718224 | Muchin | Feb 1998 | A |
5769089 | Hand et al. | Jun 1998 | A |
5890486 | Mitra et al. | Apr 1999 | A |
5931854 | Dillon | Aug 1999 | A |
5957126 | Neeser | Sep 1999 | A |
6006746 | Karell | Dec 1999 | A |
6029658 | De Voss | Feb 2000 | A |
6033422 | Blach | Mar 2000 | A |
6058931 | Muchin | May 2000 | A |
6065470 | Van Cromvoirt et al. | May 2000 | A |
6098616 | Lundy et al. | Aug 2000 | A |
6196228 | Kreitzer et al. | Mar 2001 | B1 |
6244265 | Cronk et al. | Jun 2001 | B1 |
6276360 | Cronk et al. | Aug 2001 | B1 |
6318362 | Johnson | Nov 2001 | B1 |
6357436 | Kreitzer et al. | Mar 2002 | B1 |
6375667 | Ruch | Apr 2002 | B1 |
6453901 | Ierulli | Sep 2002 | B1 |
6470883 | Beaudry | Oct 2002 | B1 |
6550474 | Anderson et al. | Apr 2003 | B1 |
6694970 | Spinelli et al. | Feb 2004 | B2 |
6769428 | Cronk et al. | Aug 2004 | B2 |
6769429 | Benetti | Aug 2004 | B1 |
7067710 | Beaudry | Jun 2006 | B1 |
7114495 | Lockwood, Jr. | Oct 2006 | B2 |
D639762 | Brogden et al. | Jun 2011 | S |
D644325 | Brunner et al. | Aug 2011 | S |
D644324 | Brunner et al. | Oct 2011 | S |
8047201 | Guyuron et al. | Nov 2011 | B2 |
8062329 | Ierulli | Nov 2011 | B2 |
D651710 | Brogden et al. | Jan 2012 | S |
8115049 | Beaudry | Feb 2012 | B2 |
D659245 | Ierulli | May 2012 | S |
8188330 | Beaudry | May 2012 | B2 |
D662203 | Smith | Jun 2012 | S |
D667543 | Ierulli | Sep 2012 | S |
D671643 | Ierulli | Nov 2012 | S |
D672461 | Brogden et al. | Dec 2012 | S |
D672872 | Brunner et al. | Dec 2012 | S |
D673270 | Brunner et al. | Dec 2012 | S |
8342173 | Lockwood, Jr. | Jan 2013 | B2 |
8444670 | Ierulli | May 2013 | B2 |
8584671 | Ierulli | Nov 2013 | B2 |
8616198 | Guyuron et al. | Dec 2013 | B2 |
8617199 | Eull et al. | Dec 2013 | B2 |
8641852 | Ierulli | Feb 2014 | B2 |
D707814 | Ierulli | Jun 2014 | S |
D707815 | Ierulli | Jun 2014 | S |
8834511 | Holmes et al. | Sep 2014 | B2 |
8834512 | Brown et al. | Sep 2014 | B1 |
8834514 | Smith | Sep 2014 | B2 |
8858587 | Ierulli | Oct 2014 | B2 |
D722161 | Reyers | Feb 2015 | S |
D722162 | Reyers | Feb 2015 | S |
D725772 | Ierulli | Mar 2015 | S |
D725773 | Ierulli | Mar 2015 | S |
9095422 | Gray | Aug 2015 | B2 |
D738496 | Peck | Sep 2015 | S |
D739015 | Martin | Sep 2015 | S |
9119620 | Peterson et al. | Sep 2015 | B2 |
D741997 | Terulli | Oct 2015 | S |
D741998 | Martin | Oct 2015 | S |
D743544 | Ierulli | Nov 2015 | S |
D743545 | Ierulli | Nov 2015 | S |
D743565 | Engel et al. | Nov 2015 | S |
D745147 | Ierulli | Dec 2015 | S |
9204988 | Fischell | Dec 2015 | B1 |
D746982 | Ierulli | Jan 2016 | S |
D747478 | Brunner et al. | Jan 2016 | S |
D753294 | Guyuron et al. | Apr 2016 | S |
D755376 | Ierulli | May 2016 | S |
D758575 | Ierulli | Jun 2016 | S |
D758576 | Ierulli et al. | Jun 2016 | S |
D759240 | Ierulli | Jun 2016 | S |
D759241 | Ierulli | Jun 2016 | S |
D759242 | Ierulli | Jun 2016 | S |
9364367 | Ierulli | Jun 2016 | B2 |
9364368 | Ierulli | Jun 2016 | B2 |
9381332 | Judd | Jul 2016 | B2 |
D764055 | Ierulli et al. | Aug 2016 | S |
D764662 | Ierulli et al. | Aug 2016 | S |
9414957 | Fischell | Aug 2016 | B1 |
9427945 | Gray et al. | Aug 2016 | B2 |
D779666 | Ierulli et al. | Feb 2017 | S |
D779667 | Ierulli et al. | Feb 2017 | S |
9566183 | Fischell | Feb 2017 | B1 |
D788298 | Guyuron | May 2017 | S |
9642995 | Fenton et al. | May 2017 | B2 |
D789531 | Ierulli | Jun 2017 | S |
D790058 | Ierulli et al. | Jun 2017 | S |
D790695 | Ierulli | Jun 2017 | S |
D791312 | Peck | Jul 2017 | S |
D791314 | Ierulli | Jul 2017 | S |
9730827 | Ierulli | Aug 2017 | B2 |
9730828 | Ierulli | Aug 2017 | B2 |
9775738 | Andre | Oct 2017 | B2 |
9844456 | Ierulli | Dec 2017 | B2 |
9901479 | Holmes | Feb 2018 | B2 |
9901480 | Ierulli | Feb 2018 | B2 |
9901481 | Ierulli | Feb 2018 | B2 |
D812749 | Ierulli | Mar 2018 | S |
D813387 | Ierulli et al. | Mar 2018 | S |
D814029 | Ierulli | Mar 2018 | S |
10010442 | Ierulli et al. | Jul 2018 | B2 |
1149781 | Ierulli | Dec 2018 | A1 |
10328625 | Gray et al. | Jun 2019 | B2 |
20080058858 | Smith | Mar 2008 | A1 |
20080097517 | Holmes et al. | Apr 2008 | A1 |
20080177253 | Boehringer et al. | Jul 2008 | A1 |
20080257341 | Ierulli | Oct 2008 | A1 |
20090125052 | Pinna et al. | May 2009 | A1 |
20090234383 | Ierulli | Sep 2009 | A1 |
20100210988 | Dallison | Aug 2010 | A1 |
20100298861 | Fenton | Nov 2010 | A1 |
20110000483 | Matthias et al. | Jan 2011 | A1 |
20110054517 | Holmes et al. | Mar 2011 | A1 |
20110166594 | Eull | Jul 2011 | A1 |
20110224717 | Lockwood | Sep 2011 | A1 |
20120004683 | Gray | Jan 2012 | A1 |
20120022582 | Guyuron | Jan 2012 | A1 |
20120067345 | Shilon | Mar 2012 | A1 |
20120172923 | Fenton | Jul 2012 | A1 |
20120209313 | Ierulli | Aug 2012 | A1 |
20120232455 | Beaudry | Sep 2012 | A1 |
20130104882 | Ierulli | May 2013 | A1 |
20130118488 | Ledogar | May 2013 | A1 |
20140194922 | Ierulli | Jul 2014 | A1 |
20140148844 | Andre | Oct 2014 | A1 |
20140296904 | Andre | Oct 2014 | A1 |
20140350596 | Smith | Nov 2014 | A1 |
20150005812 | Holmes | Jan 2015 | A1 |
20150012035 | Ierulli | Jan 2015 | A1 |
20150051636 | Lockwood | Feb 2015 | A1 |
20150090398 | Ierulli | Apr 2015 | A1 |
20150090399 | Ierulli | Apr 2015 | A1 |
20150094757 | Ierulli | Apr 2015 | A1 |
20150094758 | Ierulli | Apr 2015 | A1 |
20150216709 | Peck | Aug 2015 | A1 |
20150230966 | Ierulli | Aug 2015 | A1 |
20150250637 | Ierulli | Sep 2015 | A1 |
20150290021 | Gray | Oct 2015 | A1 |
20150359654 | Bentivegna et al. | Dec 2015 | A1 |
20160008161 | Ierulli et al. | Jan 2016 | A1 |
20160278967 | Ierulli | Sep 2016 | A1 |
20160278968 | Ierulli | Sep 2016 | A1 |
20160339619 | Gray et al. | Nov 2016 | A1 |
20170112653 | Ierulli | Apr 2017 | A9 |
20170143531 | Ierulli | May 2017 | A9 |
20170151084 | Ierulli | Jun 2017 | A9 |
20180021163 | Ierulli | Jan 2018 | A9 |
20180028346 | Ierulli | Feb 2018 | A1 |
20180071131 | Ierulli | Mar 2018 | A1 |
20190167464 | Lovato | Jun 2019 | A1 |
Number | Date | Country |
---|---|---|
355175 | Jul 1998 | EP |
289561 | Oct 1985 | ES |
Entry |
---|
Office Action dated Apr. 21, 2021 for U.S. Appl. No. 16/377,196. |
Number | Date | Country | |
---|---|---|---|
20200315835 A1 | Oct 2020 | US |